ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

OPTI Optibiotix Health Plc

18.00
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix Health Plc LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 18.00 17.50 18.50 18.00 18.00 18.00 66,018 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Noncomml Resh Organizations 457k 2.59M 0.0284 6.34 16.41M
Optibiotix Health Plc is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 18p. Over the last year, Optibiotix Health shares have traded in a share price range of 5.75p to 43.50p.

Optibiotix Health currently has 91,190,661 shares in issue. The market capitalisation of Optibiotix Health is £16.41 million. Optibiotix Health has a price to earnings ratio (PE ratio) of 6.34.

Optibiotix Health Share Discussion Threads

Showing 43126 to 43143 of 147575 messages
Chat Pages: Latest  1727  1726  1725  1724  1723  1722  1721  1720  1719  1718  1717  1716  Older
DateSubjectAuthorDiscuss
31/8/2018
08:08
Onto a twig?
rayrac
31/8/2018
07:52
Keep holding.
ken chung
31/8/2018
07:40
I think you need to look at the cashflow statement and balance sheet. What's the available cash on the balance sheet? How much did they raise? How much did they use in operating activities? Do keep up.
michaelmouse
30/8/2018
23:09
Cyberbub, i think elrico suggested around £12 million by the end of 2020. Didn't TW quote this figure in one of his updates earlier this year? Maybe i'm remembering it wrong.
incanus
30/8/2018
22:17
To reach 250p (=£200M cap) on a rapid growth p/e of 40 needs just £5M net profits. With the low M&A, and high-margin sales that usually come from licensing deals, I would suggest around £8M in revenue is required. Given the size of the partners involved in the company's recent announcements, I don't think it will be difficult to reach £8M revenue. Maybe not tomorrow, but soon enough for people willing to be patient.NAI
cyberbub
30/8/2018
22:16
Cash burn is not over £1m though is it. £300k is the 41.9% of SKINBIO cash burn which has no impact on Optis cash reserves. Do keep up
riskybusiness1
30/8/2018
21:58
Rampers are a little touchy this evening.
monkeywench1
30/8/2018
21:51
monkey your a right charlie
manc10
30/8/2018
21:30
I’m sure the dog above me is barking something about Elrico. Shows the obsession some people have with him. They probably need to get laid.
loungeact
30/8/2018
21:18
But elrampo has allowed me to join the forum! Not very robust is he!!

OH the joy of him trying to work out who i am.

monkeywench1
30/8/2018
20:33
The one where Elrico has sole discretion to let you join or not.
imnotlong
30/8/2018
20:21
What private forum?
slartybartfaster
30/8/2018
19:32
I’ve not seen that expectation of an exciting September and October comment Slarty. Is that from the private forum?
imnotlong
30/8/2018
18:56
Is anyone having trouble posting on the lemming blog?
slartybartfaster
30/8/2018
18:52
If the expectation of an exciting september and october is anything to go by, then its weeks and months.
slartybartfaster
30/8/2018
18:48
KMANN is so super smart, he confuses a meal replacement shake with a empty calorific kitkat. No hope. Best join a paid for research site, if that is the level of research.
slartybartfaster
30/8/2018
18:44
Cheers Parob. Let’s hope the newsflow materialises.

I noticed the language from SoH has changed from Elrico’s blog when he said ‘news in the next few days, weeks & months’ to ‘months and years’ in today’s RNS.

I believe short term expectations had been raised and not delivered upon. Not that my view has any bearing on anything, unlike the great KMann with his thousands of followers that listen to his every word.

imnotlong
30/8/2018
18:05
Yes still targeting £2-2.50+ by year end based on regular news flow and frequent deal announcements over the next four months. The interims didn't surprise me massively - I don't see an income lag. It is all about future hockey-style revenue growth for me, plus any bio therapeutic deals will give the shares a real boost.
parob
Chat Pages: Latest  1727  1726  1725  1724  1723  1722  1721  1720  1719  1718  1717  1716  Older

Your Recent History

Delayed Upgrade Clock